Equities research analysts at Wells Fargo & Co. began coverage on shares of IMS Health Holdings (NYSE:IMS) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set an “outperform” rating on the stock.
IMS Health Holdings (NYSE:IMS) traded down 2.23% during mid-day trading on Wednesday, hitting $23.435. The stock had a trading volume of 121,291 shares. IMS Health Holdings has a 52 week low of $21.63 and a 52 week high of $25.49. The stock has a 50-day moving average of $23.74 and a 200-day moving average of $23.74. The company has a market cap of $7.779 billion and a P/E ratio of 59.33.
A number of other firms have also recently commented on IMS. Analysts at William Blair initiated coverage on shares of IMS Health Holdings in a research note on Wednesday. They set an “outperform” rating on the stock. Separately, analysts at SunTrust initiated coverage on shares of IMS Health Holdings in a research note on Wednesday. They set a “neutral” rating and a $25.00 price target on the stock. Finally, analysts at Bank of America initiated coverage on shares of IMS Health Holdings in a research note on Wednesday. They set a “buy” rating on the stock. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $27.40.
IMS Health Holdings, Inc is a global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.